GlaxoSmithKline (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,604.00p
   
  • Change Today:
      6.60p
  • 52 Week High: 1,846.00
  • 52 Week Low: 1,374.60
  • Currency: UK Pounds
  • Shares Issued: 5,017m
  • Volume: 7,657,942
  • Market Cap: 80,477m
  • RiskGrade: 128

GlaxoSmithKline Overview

UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.

1 Day Chart (14-07-2020)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 5.0% 5.1%
Div Cover 1.5 1.5
Op Mrgn 20.6% 23.9%
ROCE 59.5%  
Latest F'cast
P/E 12.9 13.5
PEG 3.4 n/a
Pr/Revenue 2.4 2.2
Pr/Book 4.4  
Latest F'cast
Revenue 9.5% 4.8%
PBT 29.6% 35.7%
EPS 3.8% -5.8%
DPS n/a 0.0%

GlaxoSmithKline Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-15 23,923.00 10,526.00 75.70p 18.1 n/a -21% 80.00p 5.8%
31-Dec-16 27,889.00 1,939.00 102.40p 15.3 0.4 +35% 80.00p 5.1%
31-Dec-17 30,186.00 3,525.00 111.80p 11.8 1.3 +9% 80.00p 6.0%
31-Dec-18 30,821.00 4,800.00 119.40p 12.5 1.8 +7% 80.00p 5.4%
31-Dec-19 33,754.00 6,221.00 123.90p 14.4 3.6 +4% 80.00p 4.5%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

GlaxoSmithKline Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 35,360.43 8,439.37 116.70p 13.7 n/a -6% 80.00p 5.1%
31-Dec-21 36,480.29 8,825.95 119.10p 13.5 6.6 +2% 80.07p 5.1%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

GlaxoSmithKline Company Announcements

Director/PDMR Shareholding 14-Jul-2020 13:19 RNS
Director/PDMR Shareholding 13-Jul-2020 17:42 RNS
Director/PDMR Shareholding 10-Jul-2020 16:41 RNS

Latest GlaxoSmithKline Director Deals

Traded Action Notifier PriceAmountValue
10-Jul-20 Buy Dividends Emma Walmsley 1,577.33p 2,006 31,636.68
09-Jul-20 Transfer From Emma Walmsley 0.000p 8 0.00
09-Jul-20 Buy Emma Walmsley 1,610.10p 8 128.81

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

GlaxoSmithKline Market Data

Currency UK Pounds
Share Price 1,604.00p
Change Today 6.60p
% Change 0.41 %
52 Week High 1,846.00
52 Week Low 1,374.60
Volume 7,657,942
Shares Issued 5,017m
Market Cap 80,477m
RiskGrade 128

GlaxoSmithKline Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.6% below the market average33.6% below the market average33.6% below the market average33.6% below the market average33.6% below the market average
92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average
Price Trend
34.90% above the market average34.90% above the market average34.90% above the market average34.90% above the market average34.90% above the market average
36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average36.84% below the sector average
Income
76.06% above the market average76.06% above the market average76.06% above the market average76.06% above the market average76.06% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
37.52% above the market average37.52% above the market average37.52% above the market average37.52% above the market average37.52% above the market average
37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average

What The Brokers Say

Strong Buy 7
Buy 1
Neutral 11
Sell 0
Strong Sell 3
Total 22
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GlaxoSmithKline Dividends

  Latest Previous
  Q1 Q4
Ex-Div 14-May-20 20-Feb-20
Paid 09-Jul-20 09-Apr-20
Amount 19.00p 23.00p

Trades for 14-Jul-2020

Time Volume / Share Price
16:50 295 @ 1,598.60p
16:50 98 @ 1,598.60p
16:50 466 @ 1,598.60p
16:50 141 @ 1,598.60p
16:37 5,000 @ 1,604.00p

GlaxoSmithKline Key Personnel

CEO Emma Walmsley
CFO Iain Mackay

Top of Page